Under construction – not a live service
Sign in

What researchers published on Multiple myeloma

3,174 papers, newest first.

Showing 51 of 3,174

  • Systematic reviewPhysiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Observational studyDivergent Cost Trends for 3 Advanced Cancers, 2013 vs 2022: A Commercial Claims Analysis.The American journal of managed care
  • Case reportMultiorgan [18F]florbetapir PET/CT uptake in multiple myeloma-associated systemic AL amyloidosis: a case report.Medical oncology (Northwood, London, England)
  • Not labelled yetSpiritual beliefs and preferences among patients with multiple myeloma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Not labelled yetConstruction and validation of a differential diagnosis model for multiple myeloma and lymphoma based on XGBoost machine learning: an explaining analysis study of SHAP.BMC medical informatics and decision making
  • Not labelled yetGPRC5D-Directed Antibodies in Multiple Myeloma: New Agents and Frontline Strategies From IMS 2026.Clinical lymphoma, myeloma & leukemia
  • Not labelled yetModeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Not labelled yetGenomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma.JCI insight
  • Not labelled yetSustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?British journal of haematology
  • Not labelled yetIL-6-driven metabolic reprogramming of the multiple myeloma microenvironment.Cancer & metabolism
  • Case report[Multiple myeloma with central nervous system involvement successfully treated with a multimodal therapy including elranatamab].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Case report[Multiple myeloma presenting with left abducens nerve palsy due to sphenoid sinus plasmacytoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • PreprintGenomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones.bioRxiv : the preprint server for biology
  • Not labelled yetMultiple Myeloma in a Resource-Limited Setting: Clinical Presentation, Treatment Patterns, and Outcomes From a 99-Patient Cohort in Senegal.EJHaem
  • Not labelled yetFcRH5-Targeted Therapy in Multiple Myeloma: Evolving Clinical Strategies and Resistance From IMS 2026.Clinical lymphoma, myeloma & leukemia
  • Not labelled yetDaratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma.Transplantation and cellular therapy
  • Not labelled yetInfluence of CAR T-cell expansion and persistence in the peripheral blood on CAR T-cell therapy efficacy and adverse events in multiple myeloma.Bone marrow transplantation
  • Case reportUndetected Intracellular Immunoglobulin Light Chains in Aberrant Plasma Cells of Multiple Myeloma by Monoclonal Antibody-Based Flow Cytometry: A Question Raised by a Single Case.Journal of immunology research
  • ReviewBridging Innovation in Multiple Myeloma Care: A Review of Novel Therapies.Journal of the advanced practitioner in oncology
  • ReviewEarly Treatment Failure in Real-World Bispecific-Antibody Therapy for Relapsed or Refractory Multiple Myeloma: Pathways, Determinants, and Measurement Gaps.OncoTargets and therapy
  • Not labelled yetPrognostic significance of IgG-Kappa positivity detected by serum immunofixation during daratumumab therapy in multiple myeloma.Upsala journal of medical sciences
  • Case reportEpithelioid Angiosarcoma Masquerading as Multiple Myeloma: A Diagnostic Pitfall.Cureus
  • Not labelled yetCDK4/6i reverses MEIS2 inhibition of CRL4CRBN and promotes BCMA loss to enhance IMiD/CELMoD therapy in multiple myeloma.Blood neoplasia
  • Not labelled yetSociety for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of multiple myeloma, version 2.0.Journal for immunotherapy of cancer
  • Not labelled yetOrthopnea From Phrenic Nerve Palsy After Ciltacabtagene Autoleucel CAR T-Cell Therapy in a Patient With Multiple Myeloma.Journal of the advanced practitioner in oncology
  • Not labelled yetIntegrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma.Clinical hematology international
  • PreprintComputational alternative to cardiac biopsy in multiple myeloma: utilizing the shape of routine laboratory data for the classification of AL cardiac amyloidosis.bioRxiv : the preprint server for biology
  • Not labelled yetSuccinate promotes multiple myeloma cell proliferation through TCA cycle oxidation.Cell reports
  • ReviewCombination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.The Lancet. Infectious diseases
  • Case reportLenalidomide-associated B-cell acute lymphoblastic leukemia in a multiple myeloma patient: a case report.Journal of medical case reports
  • ReviewPractical Recommendations for Implementing Remote Patient Monitoring for Patients Receiving Bispecific Antibodies for Multiple Myeloma.JMIR cancer
  • Not labelled yetAI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
  • Not labelled yetStatement of Retraction: A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis.Bioengineered
  • Case report[Personalized Dosing of Lenalidomide Based on Integrated Assessment of Renal Function and Frailty in Multiple Myeloma].Gan to kagaku ryoho. Cancer & chemotherapy
  • Not labelled yetDynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab-based combination therapy.British journal of haematology
  • Not labelled yetThe impact of pomalidomide-containing induction on stem cell mobilization and engraftment in multiple myeloma: a single-center experience.Annals of hematology
  • Not labelled yetMachine-Learning-Guided Identification of CCT245737 as a Functional Pan-G-Quadruplex Ligand for the Treatment of Multiple Myeloma.The journal of physical chemistry. B
  • Not labelled yetIncreased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
  • Not labelled yetAn Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients.Transplantation and cellular therapy
  • Not labelled yetImpact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma.Blood cancer journal
  • ReviewBispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions.Cancer
  • Not labelled yetIntegration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma.British journal of haematology
  • Case reportIntrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review.AACE endocrinology and diabetes
  • Not labelled yetBone recovery after treatment study: Evidence of myeloma bone disease repair and partial microenvironment recovery.British journal of haematology
  • Not labelled yetIs Targeted Molecular Imaging of Multiple Myeloma the Future?Radiology
  • Not labelled yetPublisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.Nature medicine
  • ReviewGenomics-Guided Risk Stratification in Myeloma Precursor Conditions: Converging Frameworks From Whole-Genome Sequencing.Technology in cancer research & treatment
  • ReviewPredictors of Malnutrition in Patients With Multiple Myeloma: A Review of the Literature.Medical science monitor : international medical journal of experimental and clinical research
  • Not labelled yetWhole-body low-dose computed tomography image quality and radiation dose in multiple myeloma: A comparison between 64-slice and 128-slice scanners.Journal of clinical imaging science
  • Not labelled yetOral versus intravenous melphalan for autologous stem cell transplantation conditioning in lymphoma and multiple myeloma: a retrospective cohort study.Frontiers in oncology
  • Case reportSolitary skull lesion as the initial presentation of multiple myeloma: A case report and review of the literature.Surgical neurology international